Tri-Supply
Tri-supply is a joint venture company set up by Gilead Sciences Ltd and Lawrence Laboratories. The company was incorporated in January 2007.
It was set up to produce Atripla which is a combination of Sustiva, manufactured by Lawrence Laboratories and Truvada, manufactured by Gilead Sciences Limited. Atripla is the company’s only product.
It was the first once-daily single tablet regimen for HIV-1 infection intended as a stand-alone therapy or in combination with other antiretrovirals.
Financial Data
-
31st Dec 17 Source: CRO
- €72.7 million turnover
-
€37,763
profit
-
31st Dec 16 Source: CRO
- €98.3 million turnover
-
€44,242
profit
- 6 more years available »
Ranking
By Turnover
(€72.7 million)- 570th in Top Companies
- 60th in Pharma
-
- €72.7 million
Employees
- David Cadogan Director
Latest News
- 9:51pm Intel cuts full-year revenue forecast leading to share price fall
- 8:53pm Tullow downgrades 2019 output guidance as Ghana problems hit
- 6:14pm European shares fall as large retail and banking mergers hope dashed
- 6:14pm European shares fall as large retail, banking mergers hope dashed
- 6:00pm Plan for vertical extension to Docklands office block put on hold